Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > OT -- Update on my wife

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Jun 28, 2022 1:17pm

170 Views

Post# 34787992

RE:RE:RE:RE:RE:RE:RE:OT -- Update on my wife

So sorry to hear that. I trust you have many fond memories of the time you had togther and that life is already making up for what it has taken from you. As you know, life and investing share a common thread of surpising us with unexpected developments, both good and bad. May the Lord grant you an excess supply of unexpected good tidings to help you overcome your loss.

Momo25 wrote: I wish you all the best. I know it's tough ! Very tough, not only for the sick person but for all the familiy around. I went throug this misery 3 years ago when my wife was diagnosed with cancer. Unfortunately she couldn't make it .

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China